These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7814531)

  • 81. In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test.
    Nenoff P; Oswald U; Haustein UF
    Mycoses; 1999; 42(11-12):629-39. PubMed ID: 10680439
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Rapid flow cytometric susceptibility testing of Candida albicans.
    Ramani R; Ramani A; Wong SJ
    J Clin Microbiol; 1997 Sep; 35(9):2320-4. PubMed ID: 9276410
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparative evaluation of FUNGITEST and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
    Davey KG; Holmes AD; Johnson EM; Szekely A; Warnock DW
    J Clin Microbiol; 1998 Apr; 36(4):926-30. PubMed ID: 9542910
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
    Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
    Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
    Yamane N; Igari J
    Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media.
    Pfaller MA; Messer SA; Houston A; Mills K; Bolmstrom A; Jones RN
    J Clin Microbiol; 2000 Oct; 38(10):3715-7. PubMed ID: 11015389
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.
    Kronvall G; Karlsson I
    J Clin Microbiol; 2001 Apr; 39(4):1422-8. PubMed ID: 11283066
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species.
    Kauffman CA; Zarins LT
    Mycoses; 1999; 42(9-10):539-42. PubMed ID: 10592697
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
    Araj GF; Daher NK; Tabbarah ZA
    Int J Antimicrob Agents; 1998 Nov; 10(4):291-6. PubMed ID: 9916903
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.
    Pfaller MA; Andes D; Diekema DJ; Espinel-Ingroff A; Sheehan D;
    Drug Resist Updat; 2010 Dec; 13(6):180-95. PubMed ID: 21050800
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts.
    Fromtling RA; Galgiani JN; Pfaller MA; Espinel-Ingroff A; Bartizal KF; Bartlett MS; Body BA; Frey C; Hall G; Roberts GD
    Antimicrob Agents Chemother; 1993 Jan; 37(1):39-45. PubMed ID: 8431016
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Multicenter evaluation of the new Vitek 2 yeast susceptibility test using new CLSI clinical breakpoints for fluconazole.
    Pfaller MA; Diekema DJ; Procop GW; Wiederhold NP
    J Clin Microbiol; 2014 Jun; 52(6):2126-30. PubMed ID: 24719450
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program.
    Pfaller MA; Boyken LB; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2008 Nov; 46(11):3585-90. PubMed ID: 18784314
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis.
    Arthington-Skaggs BA; Warnock DW; Morrison CJ
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2081-5. PubMed ID: 10898679
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans.
    Kirkpatrick WR; McAtee RK; Revankar SG; Fothergill AW; McCarthy DI; Rinaldi MG; Patterson TF
    J Clin Microbiol; 1998 May; 36(5):1330-2. PubMed ID: 9574699
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts.
    Cook RA; McIntyre KA; Galgiani JN
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1542-5. PubMed ID: 2221863
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012.
    Pfaller MA; Diekema DJ
    J Clin Microbiol; 2012 Sep; 50(9):2846-56. PubMed ID: 22740712
    [TBL] [Abstract][Full Text] [Related]  

  • 99. In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy.
    McIntyre KA; Galgiani JN
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1095-100. PubMed ID: 2551215
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test.
    Rodríguez-Tudela JL; Martinez-Suarez JV
    J Clin Microbiol; 1997 Jan; 35(1):336-7. PubMed ID: 8968944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.